Zobrazeno 1 - 10
of 147
pro vyhledávání: ''
Autor:
Gisel L. Fattore, Natalia S. Aráoz Olivos, José E. Carrizo Olalla, Lara Gomez, Agustina Flamenco Marucco, María Paz Rojas Mena
Publikováno v:
Cancer epidemiology. 79
Cancer is an important risk factor in patients with COVID-19. We aimed to describe the clinical and demographic characteristics associated with mortality in patients with cancer who were infected with SARS-CoV-2.We conducted a retrospective longitudi
Autor:
Jon Shelton, Victoria H. Coupland, Jodie Moffat, Veronique Poirier, Roland Valori, Sara Hiom, Clare Pearson, Georgios Lyratzopoulos, Michael D Peake, Sean McPhail, Jess Fraser
Publikováno v:
Cancer Epidemiology. 61:111-118
Background Diagnostic timeliness in cancer patients is important for clinical outcomes and patient satisfaction but, to-date, continuous monitoring of diagnostic intervals in nationwide incident cohorts has been impossible in England. Methods We deve
Autor:
Theodosia Salika, Demian Jardel, Tra My Pham, Gary A. Abel, Mayam Gomez-Cano, Georgios Lyratzopoulos
Publikováno v:
Cancer Epidemiology. 61:70-78
Background Whether diagnostic route (e.g. emergency presentation) is associated with cancer care experience independently of tumour stage is unknown. Methods We analysed data on 18 590 patients with breast, prostate, colon, lung, and rectal cancers w
Autor:
Gabrielle Emanuel, David Dodwell, Katherine E Henson, John Broggio, Jackie Charman, Kieran Horgan, Sarah C. Darby
Publikováno v:
Cancer Epidemiology
Highlights • Prescribing was as expected from clinical practice. • 90% received ET prescriptions during the second year after diagnosis. • Prescribing dropped more than five years after diagnosis. • The majority of younger women (under 55) re
Autor:
Yasan Kazemzadeh, Zahra Sharafi, Hosein Hoseini-hoshyar, Alireza Sadjadi, Seyed Mohammad Tavangar, Zahra Ravankhah, Maria Cheraghi, Gohar Mohammadi, Arash Golpazir, Mostafa Khoshaabi, Hakimeh Abadi, Aliakbar Zareiyan, Hamed Zandian, Zeinab Tahmasebi, Reza Malekzadeh, Parvin Joola, Mohsen Farmahini Farahani, Mohamadreza Behrooz, Ghasem Janbabaei, Mansooreh Fateh, Azadeh Poornajaf, Reza Malekpour-Afshar, Kazem Zendehdel, Abasali Asgari, Hossein Poustchi, Ahmad Jalilvand, Narjes Hazar, Maryam Khalednejad, Maryam Soltany-hojatabad, Gholamhasan Mohamadzadeh, Afshin Ostovar, Zeinab Moinfar, Ali Ghanbari-Motlagh, Maryam Kooshki, Fereshteh Salavati, Farroq Sharifi-moghadam, Floria Enferadi, Gholamreza Roshandel, Gholamreza Sadeghi, Sohrab Yadolahi, Elham Partovipour, Susan Hasanpour-Heidari, Amir-Hossein Bayat, Mahdi Jahantigh, Ali Jafarnia, Alireza Reisi, Abbas Rezaeianzadeh, Majid Yaghoubi-ashrafi, Amineh Madani, Amir Rahnama, Khadijeh Rezaei, Roya Dolatkhah, Bahman Rashidpour, Siamak Vahedi, Athar Shahdadi, Sharareh Niksiar, Masoud Davanlou, Mahdieh Hasanzadeh, Rita Motidost-komleh, soodabeh Esshaghi, Ali Soleimani, Solmaz Farrokhzad, Mehrdad Jazayeri, Leila Danechin, Habibollah Pirnejad, Mehraban Shahi, Hosein Mohamadifar, Mohsen Izadi, Mahboobeh Narooei, Gita Pourshahi
Publikováno v:
Cancer Epidemiology. 61:50-58
Background We aimed to report, for the first time, the results of the Iranian National Population-based Cancer Registry (INPCR) for the year 2014. Methods Total population of Iran in 2014 was 76,639,000. The INPCR covered 30 out of 31 provinces (98%
Autor:
Paul C Jutte, Joris J W Ploegmakers, H.W.B. Schreuder, Albert J. H. Suurmeijer, Ingrid C.M. van der Geest, Sander P. D. S. Dijkstra M.D., Vincent K Y Ho, Jos A. M. Bramer, Gerard R. Schaap, Louren M Goedhart, Michiel A. J. van de Sande
Publikováno v:
Cancer epidemiology, 60, 31-38. Elsevier BV
Cancer Epidemiology, 60, 31-38. ELSEVIER SCI LTD
Cancer epidemiology, 60, 31-38. ELSEVIER SCI LTD
Cancer Epidemiology, 60, pp. 31-38
Cancer Epidemiology, 60, 31-38
Cancer Epidemiology, 60, 31-38. ELSEVIER SCI LTD
Cancer epidemiology, 60, 31-38. ELSEVIER SCI LTD
Cancer Epidemiology, 60, pp. 31-38
Cancer Epidemiology, 60, 31-38
Aims: Chondrosarcoma, osteosarcoma and Ewing sarcoma form the majority of malignant primary tumours of bone. High-grade bone sarcomas require intensive treatment due to their rapid and invasive growth pattern and metastasising capabilities. This nati
Autor:
Anders Holmén, Erik Holmberg, Ulf Strömberg, Mef Nilbert, Stefan Peterson, Rolf Hultcrantz, Anna Martling
Publikováno v:
Cancer Epidemiology. 60:23-30
Background Sociodemographic and spatial disparities in incidence and mortality burden of colorectal cancer (CRC) are important to consider in the implementation of population screening, in order to achieve expected benefit and not increase health ine
Autor:
Efi Kokkotou, G. Stefanou, Georgia Kourlaba, Ioannis Gkiozos, Konstantinos N. Syrigos, A. Papaspiliou
Publikováno v:
Cancer Epidemiology. 60:193-200
To map the patients' journey from symptoms onset to treatment initiation for the most frequent histological types of lung cancer in Greece and describe the initial treatment that patients receive.The primary data source was a Greek hospital-based reg
Autor:
Kaustubh Bora
Publikováno v:
Cancer Epidemiology. 59:215-220
Background This study aimed to investigate the distribution of multiple myeloma (MM) in India and provide a comprehensive narrative about its incidence, including differential patterns across age, sex and geography. Methods MM cases diagnosed during
Autor:
Sonia Benzarti, Georg Stussi, Nicolas Bonadies, Rudolf Benz, Max Solenthaler, Anita Feller, Volker Arndt, Michael Daskalakis, Andreas Holbro, Annatina Schnegg-Kaufmann, Vera Ulrike Bacher, Adrian Schmidt, Axel Rüfer
Publikováno v:
Cancer Epidemiology. 59:51-57
Chronic myelomonocytic leukemia (CMML) is a rare hematopoietic malignancy. Treatment with hypomethylating agents (HMA) was introduced between 2004 and 2006 but its impact on population-based survival remains controversial. The aim of this study was t